ctDNA in Pancreatic and Colorectal Cancer

How ctDNA testing is being investigated and used in pancreatic and colorectal cancer in the era of precision medicine.

EP. 11: Assessing the Full Potential of ctDNA in Colorectal Cancer

March 22nd 2022

Gregory P. Botta, MD, PhD, highlights key trials of interest exploring ctDNA analyses to better inform treatment decisions for patients with rectal cancers.

EP. 12: Investigating the Role of ctDNA in Colorectal Cancer: Next Steps

March 22nd 2022

Abstracts presented during ASCO GI 2022 and other initiatives in clinical trials, assessing treatment strategies for patients with colorectal cancer based on ctDNA negativity or positivity.

EP. 13: Incorporating ctDNA Into Routine Practice: Clinical Pearls

March 22nd 2022

Advice to GI oncologists in the community on using ctDNA testing to detect minimal residual disease and inform treatment decisions in colorectal cancer.